Literature DB >> 21524341

Age factor and implication of human papillomavirus type-specific prevalence in women with normal cervical cytology.

C H Lai1, A Chao, C J Chang, C C Huang, L C Wang, S Hsueh, C T Lin, T I Wu, M S Jao, H H Chou.   

Abstract

The prevalence and genotype distribution of human papillomavirus (HPV) infection in women with normal cervical cytology varies widely according to the population studied. Two non-overlapping population-based cohort studies of women aged ≥30 years for the periods 2008-2009 (n=5026) and 2004-2005 (n=10 014) were analysed. The prevalence rate of HPV was 11·0% (95% CI 10·5-11·6). HPV infection was significantly associated with age, menopausal status, and inversely associated with hormone replacement therapy. There was an increasing trend of α3/α15, α5/α6, and multiple HPV infections with increasing age. The five most common types were HPV52, 18, 53, 58 and 70, while HPV16, 31, 33 ranked 21st, 25th, and 16th, respectively, in the merged cohort with normal cytology (n=14 724). HPV16, 31, and 33 were significantly associated with abnormal cytology, which could have resulted in their rarity in the total merged cohort (n=15 040).

Entities:  

Mesh:

Year:  2011        PMID: 21524341     DOI: 10.1017/S0950268811000720

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  2 in total

1.  The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China.

Authors:  Shizhuo Wang; Heng Wei; Ning Wang; Shulan Zhang; Yao Zhang; Qiang Ruan; Weiguo Jiang; Qian Xiao; Xiaomei Luan; Xiuyan Qian; Lili Zhang; Xiang Gao; Xiaowei Sun
Journal:  BMC Cancer       Date:  2012-05-01       Impact factor: 4.430

2.  Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest China.

Authors:  Zheng Li; Feng Liu; Si Cheng; Lei Shi; Zhiling Yan; Jie Yang; Li Shi; Yufeng Yao; Yanbing Ma
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.